Starling Oncology Inc. STLN
NASDAQ · United States · Health Services
$6.28-0.04 (-0.71%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.08 | -0.06 | -25.0% | $161.28M | +3.6% | +27.4%$5.03→$6.41 |
| Q1 2026 | 2026-05-07 | -0.02 | -0.07 | +71.4% | — | — | +5.3%$3.80→$4.00 |
| Q4 2025 | 2026-03-12 | -0.06 | -0.09 | +33.3% | — | — | +2.9%$2.76→$2.84 |
| Q3 2025 | 2025-11-13 | -0.14 | -0.11 | -27.3% | — | — | +15.7%$3.43→$3.97 |
| Q2 2025 | 2025-08-13 | -0.15 | -0.12 | -25.0% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.14 | -0.10 | -40.0% | — | — | — |
| Q1 2024 | 2024-05-14 | -0.19 | -0.12 | -58.3% | — | — | — |
| Q4 2023 | 2024-03-26 | -0.16 | -0.11 | -45.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.